BCL2 gene abnormalities define distinct clinical subsets of follicular lymphoma

Histopathology

Volumn 49, Issue 3, 2006, Pages 229-241

  Goodlad, J R ^a,c   Batstone, P J ^b   Hamilton, D A ^b   Kernohan, N M ^c   Levison, D A ^c   White, J M ^d  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b RAIGMORE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

BCL2; Classification; Extranodal; Follicular lymphoma; Skin

Indexed keywords

CHLORAMBUCIL; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; PROTEIN BCL 2; PROTEIN BCL 6; VINCRISTINE SULFATE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BCL2 GENE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CELL ONCOGENE; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; CLINICAL ARTICLE; COHORT ANALYSIS; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; LARGE CELL LYMPHOMA; MALE; PATHOLOGICAL ANATOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN LYMPHOMA; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; FEMALE; GENES, BCL-2; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEPRILYSIN; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL ANALYSIS; TRANSLOCATION, GENETIC;

EID: 33747388722     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2006.02501.x     Document Type: Article

References (33)

1. Sanchez-Beato M, Sanchez-Aguilera A, Piris MA. Cell cycle deregulation in B-cell lymphomas. Blood 2003; 101; 1220-1235.
2. Voutsadakis IA. Apoptosis and the pathogenesis of lymphoma. Acta Oncologica 2000; 39; 151-156.
3. Seymour JF. New treatment approaches to indolent non-Hodgkin's lymphoma. Semin. Oncol. 2004; 31 (1 Suppl. 2); 27-32.
4. Isaacson PG, Norton AJ. Cutaneous lymphoma. In Isaacson PG, Norton AJ eds. Extranodal lymphomas. Edinburgh: Churchill Livingstone 1994; 131-191.
5. Slater DN. MALT and SALT: the clue to cutaneous B-cell lymphoproliferative disease. Br. J. Dermatol. 1994; 131; 557-561.
6. Cerroni L, Arzberger E, Putz B et al. Primary cutaneous follicle center cell lymphoma with follicular growth patern. Blood 2002; 95; 3922-3928.
7. Child FJ, Russell-Jones R, Woolford AJ et al. Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma. Br. J. Dermatol. 2001; 144; 735-744.
8. Franco R, Fernandez-Vazquez A, Rodriguez-Peralto JL et al. Cutaneous follicular B-cell lymphoma: description of a series of 18 cases. Am. J. Surg. Pathol. 2001; 25; 875-883.
9. Goodlad JR, Krajewski AS, Batstone PJ et al. Primary cutaneous follicular lymphoma. A clinicopathologic and molecular study of 16 cases in support of a distinct entity. Am. J. Surg. Pathol. 2002; 26; 733-741.
10. Poggie MM, Cong PJ, Coleman CN, Jaffe ES. Low-grade follicular lymphoma of the small intestine. J. Clin. Gastroenterol. 2002; 34; 155-159.
11. Yoshino T, Miyake K, Ichimura K et al. Increased incidence of follicular lymphoma in the duodenum. Am. J. Surg. Pathol. 2000; 24; 688-693.
12. Bende RJ, Smit LA, Bossenbroek JG et al. Primary follicular lymphoma of the small intestine: alpha4beta7 expression and immunoglobulin configuration suggest an origin from local antigen-experienced B cells. Am. J. Pathol. 2003; 162; 105-113.
13. Damaj G, Verkarre V, Delmer A et al. Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. Ann. Oncol. 2003; 14; 623-629.
14. Shia J, Teruya-Feldstein J, Pan D et al. Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 cases. Am. J. Surg. Pathol. 2002; 2; 216-224.
15. Ott G, Katzenberger T, Lohr A et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood 2002; 99; 3806-3812.
16. Bosga-Bouwer AG, van Imhoff GW, Boonstra R et al. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27 or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood 2003; 101; 1149-1154.
17. Horsman DE, Okamoto I, Ludkovski O et al. Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes. Br. J. Haematol. 2003; 120; 424-433.
18. Kojima M, Nakamura S, Ichimura K et al. Follicular lymphoma of the salivary gland: a clinicopathological and molecular study of six cases. Int. J. Surg. Pathol. 2001; 9; 287-293.
19. Pileri SA, Sabattini E, Rosito P et al. Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics. J. Clin. Pathol. 2002; 55; 684-688.
20. Goodlad JR, MacPherson S, Jackson R, Batstone P, White J. Extranodal follicular lymphoma: a clinicopathological and genetic analysis of 15 cases arising at non-cutaneous extranodal sites. Histopathology 2004; 44; 268-276.
21. Bergman R, Kurtin PJ, Gibson LE et al. Clinicopathologic, immunophenotypic, and molecular characterization of primary cutaneous follicular B-cell lymphoma. Arch. Dermatol. 2001; 137; 432-439.
22. Lawnicki LC, Weisenburger DD, Aoun P et al. The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphoma: association with lower grade. Am. J. Clin. Pathol. 2002; 118; 765-772.
23. Mirza I, MacPherson N, Paproski S et al. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features. J. Clin. Oncol. 2002; 20; 647-655.
24. Nathwani BN, Piris MA, Harris NL et al. Follicular lymphoma. In Jaffe ES, Harris NL, Stein H et al. eds. World Health Organization classification of tumours: pathology and genetics. Tumours of the haematopoetic and lymphoid tissues. Lyon: IARC Press 2001; 162-167.
25. Batstone PJ, Goodlad JR. Efficacy of screening the intermediate cluster region of the bcl2 gene in follicular lymphomas by PCR. J. Clin. Pathol. 2005; 58; 81-82.
26. Rantanen S, Monni O, Joensuu H et al. Causes and consequences of BCL2 overexpression in diffuse large B-cell lymphoma. Leukemia Lymphoma 2001; 42; 1089-1098.
27. Maes B, De Wolf-Peeters C. Marginal zone cell lymphoma - an update on recent advances. Histopathology 2002; 40; 117-126.
28. Swerdlow SH, Berger F, Isaacson PG et al. Mantle cell lymphoma. In Jaffe ES, Harris NL, Stein H et al. eds. World Health Organization classification of tumours: pathology and genetics. Tumours of the haematopoetic and lymphoid tissues. Lyon: IARC Press 2001; 168-170.
29. Turner GE, Ross FM, Krajewski AS. Detection of t(14;18) in British follicular lymphoma using cytogenetics, Southern blotting and the polymerase chain reaction. Br. J. Haematol. 1995; 89; 223-225.
30. de Leval L, Harris NL, Longtine J et al. Cutaneous B-cell lymphomas of follicular and marginal zone types: use of bcl-6, CD10, bcl-2 and CD21 in differential diagnosis and classification. Am. J. Surg. Pathol. 2001; 25; 732-741.
31. Leoncini L, Lazzi S, Bellan C et al. Cell kinetics and cell cycle regulation in lymphomas. J. Clin. Pathol. 2002; 55; 648-655.
32. Hollowood K, Goodlad JR. Germinal centre cell kinetics. J. Pathol. 1998; 185; 229-233.
33. Zha H, Raffeld M, Charboneau L et al. Similarities of prosurvival signals in Bcl-2 positive and Bcl-2 negative follicular lymphomas identified by reverse phase protein microarray. Lab. Invest. 2004; 84; 235-244.